Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01585311 · ClinicalTrials.gov registry record
Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 1,540
- Enrollment target
NCT01585311 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 1,540 participants.
The verdict
NCT01585311 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 1,540 participants
- Enrollment target
Study Summary
The purpose of this retrospective study is to test the hypothesis that uncontrolled tachycardia serves as a risk factor for adverse cardiovascular events and poor outcome after Subarachnoid Hemorrhage (SAH).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,540 participants |
| Start Date | 2008-03 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01585311
The ClinicalTrials.gov registry entry for NCT01585311 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,540 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01585311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01585311 about?
NCT01585311 is a clinical study titled "Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)". The purpose of this retrospective study is to test the hypothesis that uncontrolled tachycardia serves as a risk factor for adverse cardiovascular events and poor outcome after Subarachnoid Hemorrhage (SAH).
What is the current status of trial NCT01585311?
This trial is currently terminated. The enrollment target is 1,540 participants. The study started on 2008-03. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT01585311?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.